Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 1/20 | 0.58 |
| ▸ | MC5R | P33032 | 1/20 | 0.58 |
| ▸ | MC3R | P41968 | 1/20 | 0.58 |
| ▸ | MC1R | Q01726 | 1/20 | 0.58 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.57 |
| ▸ | NMUR1 | Q9HB89 | 3/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.57 |
| ▸ | NPY2R | P49146 | 7/20 | 0.57 |
| ▸ | NPY4R | P50391 | 7/20 | 0.57 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.57 |
| ▸ | NPY1R | P25929 | 5/20 | 0.57 |
| ▸ | TFPI | P10646 | 4/20 | 0.57 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.56 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30842159 | 0.92 | NMUR2 (0.64) | MC4RMC5RMC3RMC1RNMUR2 | |
| SCHEMBL29489270 | 0.91 | TFPI (0.58) | MC4RMC5RMC3RMC1RNMUR2 | |
| SCHEMBL29410232 | 0.89 | KEAP1 (0.67) | NMUR2NMUR1NPY2RNPY4RNPY5R | |
| SCHEMBL30842169 | 0.89 | NMUR2 (0.65) | MC4RMC5RMC3RMC1RNMUR2 | |
| SCHEMBL29489266 | 0.89 | TFPI (0.64) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL30495837 | 0.89 | OPRM1 (0.61) | MC4RMC5RMC3RMC1RNMUR2 | |
| SCHEMBL30176214 | 0.88 | KDM1A (0.60) | NMUR2NMUR1NPY2RNPY4RNPY5R | |
| SCHEMBL29854575 | 0.87 | NPY2R (0.58) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL29477190 | 0.87 | TFPI (0.61) | NMUR2NMUR1OPRM1TFPI | |
| SCHEMBL30842195 | 0.86 | TFPI (0.65) | OPRM1OPRD1TFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552848-B2 | Hydrochloride salts of C5a receptor agonist peptides | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2026-02-17 | — | — | US | claimed |
| US-20240238414-A1 | ANTI-PARASITIC IMMUNOLOGICAL COMPOSITIONS | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2024-07-18 | — | — | US | claimed |
| US-12552848-B2 | Hydrochloride salts of C5a receptor agonist peptides | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2026-02-17 | — | — | US | disclosed |
| US-20240238414-A1 | ANTI-PARASITIC IMMUNOLOGICAL COMPOSITIONS | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2024-07-18 | — | — | US | disclosed |
| US-11911464-B2 | Anti-parasitic immunological compositions | PROMMUNE, INC. (US) | 2024-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552848-B2 | Hydrochloride salts of C5a receptor agonist peptides | C5AR1, C5AR2, C3AR1 | MC4R 62/4885MC5R 105/4885MC3R 113/4885 |
| US-20240238414-A1 | ANTI-PARASITIC IMMUNOLOGICAL COMPOSITIONS | C3AR1, C5AR1, C5AR2 | MC4R 2160/4885MC5R 2264/4885MC3R 2303/4885 |
| US-11911464-B2 | Anti-parasitic immunological compositions | C3AR1, C5AR1, C5AR2 | MC4R 2160/4885MC5R 2264/4885MC3R 2303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.